Martin Orduno: Focused on minimally invasive surgery to ensure faster recovery times
90.7%), who were randomized to either metformin monotherapy, or early combination therapy with metformin plus vildagliptin (a dipeptidyl peptidase-4 inhibitor) [65,67]
Both Neeland and Ahmed say more research is needed on the health effects from short-term use of GLP-1s
Why are GLP-1 agonists being used for NAFLD
Major adverse cardiovascular events (MACE) The research examined eight large cohorts of T2DM patients, with cardiovascular outcome trials (CVOTs), for main MACE outcomes, including cardiovascular death, nonfatal MI, and nonfatal stroke, which were studied with GLP1RAs [40]
People with nutrient deficiencies often see remarkable changes, as modern food can lack sufficient nutrients